Boston Scientific Corporation(BSX)Stock Performance & ReturnsNYSE
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
BSX | 66.06 B | 18.45x | 7.50% | 17.50% | $2.47 | 15.34% | 0.50x | 0.00% | $105.65 | $41.39 |
ABT | 177.28 B | 33.05x | 13.00% | 11.65% | $3.10 | 10.58% | 0.63x | 2.42% | $128.83 | $80.89 |
ISRG | 154.74 B | 50.23x | 18.50% | 28.45% | $8.72 | 17.42% | - | 0.00% | $603.88 | $328.57 |
SYK | 116.76 B | 31.54x | 9.40% | 14.43% | $9.65 | 16.51% | 0.64x | 1.14% | $388.25 | $266.16 |
EW | 50.89 B | 52.55x | 13.60% | 15.43% | $1.68 | 9.18% | 0.07x | 0.00% | $96.29 | $74.66 |
Peer Valuation & Performance Analysis
Peer group analysis for Boston Scientific Corporation (BSX) compared to its primary competitors (including ABT, ISRG, SYK) reveals distinct metrics. BSX trades at a valuation discount relative to its competitors, with a P/E ratio of 18.5x versus the peer average of 41.8x (representing a 56% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, BSX's revenue growth of 7.5% lags behind the peer average of 13.6%, indicating potential market share losses or slower industry adoption. Additionally, its net margin of 17.5% is comparable to the peer average of 17.5%.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• BSX ranks #1 in P/E ratio, #5 in revenue growth, and #2 in profit margins
• Average ranking: #3 - 📊 Solid financials relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-21 | $45.04 | $45.64 | $43.91 | $44.51 | 15,185,668 | -2.35% |
| 2026-10-20 | $45.67 | $46.05 | $45.15 | $45.58 | 16,011,500 | +1.18% |
| 2026-10-19 | $44.01 | $45.10 | $43.94 | $45.05 | 13,964,900 | +1.49% |
| 2026-10-16 | $44.45 | $44.83 | $43.89 | $44.39 | 12,409,700 | +0.57% |
| 2026-10-15 | $43.95 | $44.43 | $43.46 | $44.14 | 15,860,000 | +2.65% |
| 2026-10-14 | $43.40 | $43.58 | $42.28 | $43.00 | 15,103,200 | -0.72% |
| 2026-10-13 | $43.95 | $44.15 | $42.46 | $43.31 | 14,273,900 | -1.21% |
| 2026-10-12 | $43.10 | $43.92 | $42.67 | $43.84 | 13,596,400 | +2.60% |
| 2026-10-09 | $42.12 | $42.83 | $41.97 | $42.73 | 13,036,100 | +1.64% |
| 2026-10-08 | $41.50 | $42.27 | $41.39 | $42.04 | 22,873,400 | +1.11% |
| 2026-10-07 | $42.19 | $42.52 | $41.50 | $41.58 | 15,892,400 | -1.45% |
| 2026-10-06 | $42.47 | $42.75 | $42.00 | $42.19 | 12,545,600 | -0.50% |
| 2026-10-05 | $42.53 | $43.30 | $42.29 | $42.40 | 13,737,400 | -0.47% |
| 2026-10-02 | $43.32 | $43.44 | $41.94 | $42.60 | 18,313,900 | -1.46% |
| 2026-10-01 | $43.51 | $43.96 | $42.95 | $43.23 | 17,931,800 | -0.96% |
Explore More Analysis for BSX
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.